US Patent 11866499 Monospecific and multispecific anti-TMEFF2 antibodies and their uses
Patent 11866499 was granted and assigned to Janssen Biotech on January, 2024 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
May 21, 2019
0
Date of Patent
January 9, 2024
0
Patent Applicant
Patent Application Number
16417889
0
Patent Inventor Names
Sheng-Jiun Wu
0
Philip Cooper
0
Rajkumar Ganesan
0
Sathyadevi Venkataramani
0
Michael Russell
0
Sanjaya Singh
0
Colleen Kane
0
Robin Ernst
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
CPC Code
Find more entities like US Patent 11866499 Monospecific and multispecific anti-TMEFF2 antibodies and their uses
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
